Citizen jury should consider aspirin prophylaxis [2]

British Medical Journal

Volumn 331, Issue 7509, 2005, Pages 160-

  Iredale, Rachel T ^a  

^a UNIVERSITY OF GLAMORGAN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGE DISTRIBUTION; ANALGESIA; DECISION MAKING; HUMAN; LETTER; PRIORITY JOURNAL; PROPHYLAXIS; RISK BENEFIT ANALYSIS; THROMBOSIS PREVENTION; UNITED KINGDOM;

ASPIRIN; CARDIOVASCULAR DISEASES; HUMANS; PATIENT PARTICIPATION; PLATELET AGGREGATION INHIBITORS;

EID: 22344447291     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. This week in the BMJ. Aspirin to prevent cardiovascular disease in elderly people: the jury's still out. BMJ 2005;330. (4 June.)
2. Nelson MR, Liew D, Bertram M, Vos T. Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged 70. BMJ 2005;330:1306. (4 June.)